Literature Review

The Green Wave: Medical marijuana patient enrollment grew 610% since 2016 InvestingDaily, by John Persinos; 4/18/24 The Centers for Disease Control and Prevention (CDC), the Department of Veterans Affairs (VA), and the University of Michigan recently issued a report about a staggering surge in enrollment in state-sanctioned medical marijuana programs across the nation. The report was published last week by the journal Annals of Internal Medicine. Between 2016 and 2020, the number of patients enrolled in medical marijuana programs in the U.S. grew “dramatically,” the report says, rising from about 678,000 in 2016 to more than 3 million in 2020. “This analysis indicates a 610% increase in patient number in the United States from 2016 to 2022,” the report states.

Over 1,200 medical marijuana cards issued ahead of Qualla Boundary dispensary opening Blue Ridge Public Radio News, by Lilly Knoepp; 4/16/24 This Saturday, North Carolina will become the 39th state with access to medical marijuana as the Eastern Band of Cherokee opens the first marijuana dispensary in the state. The Great Smoky Cannabis Company will host a ribbon cutting ceremony followed by a grand opening at 10 a.m. A spokesperson for ECBI said preparations for the opening have involved a variety of stakeholders. ... In March, ... a total of 1,200 cards had been issued. Now, he says, there have been 3,000 applications submitted to the board.

Medical marijuana laws benefit patients without harming public mental health, study finds ScienceBlog, University of Basel; 4/4/24 A study by researchers at the University of Basel has found that the approval of marijuana for medical use in the United States has had little impact on the mental health of the general population, while benefiting those for whom it is intended. The study, which analyzed data from nearly eight million people, sheds light on the ongoing debate surrounding the effects of marijuana legalization on public well-being and its therapeutic value.

Connecticut Appellate Court rules employer could discharge medical marijuana user impaired on the job The National Law Review; by John G. Stretton, Nicole S. Mulé, Zachary V. Zagger of Ogletree, Deakins, Nash, Smoak & Stewart, P.C.; 3/27/24 On March 19, 2024, the Connecticut Appellate Court upheld an employer’s right to discharge an employee for being impaired on the job from medical marijuana under a state law that provides employment protections for qualified medical marijuana users.

Medical marijuana law does not impair employers’ right to drug-free workplace Insurance Journal, by Andrew G. Simpson; 3/22/24 A Connecticut employer has the right to terminate an employee who is impaired by medical marijuana in the workplace. The Connecticut Appellate Court on March 19 upheld the dismissal of a lawsuit brought against a nonprofit pre-school by a teaching assistant who used medical marijuana for treatment of her disability and was fired for violating the school’s drug-free workplace policy by showing up for work impaired. 

Where states stand on medical marijuana in the workplace JD Supra, by Madalyn Cohee; 3/18/24 A federal judge in Vermont last month ruled a plaintiff’s medical marijuana use was not protected by the Americans with Disabilities Act. In Skoric v. Marble Valley Regional Transit District et al., the plaintiff was fired by his employer for failing a random drug test by testing positive for marijuana despite having a valid, state-issued medical marijuana card and being prescribed medical marijuana to treat his chronic pain and depression.

Could Kansas adopt medical cannabis pilot program? Legislation in the works Kansas News, by Rebekah Chung; 3/1/24Medical marijuana advocates are crafting proposals for this session. Nexstar’s Kansas Capitol Bureau confirmed that a medical cannabis pilot program proposal is in the works. The future of marijuana reform lies in the Kansas Senate’s hands, as the House awaits action.

MMJ.com expands access to Medical Marijuana cards across 26 states in the US Newsfile Corp., 3/1/24 In a significant development for healthcare and legal access to medical marijuana in the United States, MMJ.com has announced its expansion to offer services across 26 states. This initiative represents a pivotal moment in the ongoing effort to provide patients with legal, safe, and convenient access to medical marijuana, reflecting changing societal attitudes and advancements in telehealth.

Medical marijuana testing: Mississippi revokes license of lab that covered 70% of state's supply, raising patient access concerns Benzinga - Investing.com; by Maureen Meehan; 2/25/24Mississippi’s Department of Health (MSDH) revoked the license of Rapid Analytics, a medical cannabis testing lab, citing “significant deviations from regulations” following a two-month investigation. 

Exploring the role of medicinal cannabis in palliative careMicrodose, by Keith Fiveson; 2/19/24Palliative care is a crucial aspect of healthcare, aiming to enhance the quality of life for patients facing incurable illnesses. Within this context, the use of medicinal cannabis (MC) has emerged as a potential avenue for addressing various symptoms and improving overall well-being. This article delves into a systematic review conducted by Marjan Doppen and colleagues, which examines the current evidence surrounding MC’s effects and potential harms in palliative care settings.

Where things stand: a summary of pending federal cannabis legislationReuters, Jean E. Smith-Gonnell and Cole White; 2/8/247Federal legislation pertaining to cannabis reform, once a political oddity, now commands significant resources and attention in Congress. With numerous bills under consideration, the landscape is both dynamic and complex. ... In this overview, we aim to provide clarity amidst the legislative maze and get to the root of the most significant cannabis legislation introduced in 2023. 

What to know about the federal government’s big changes to marijuana rules coming soonCannabis Business Executive (CBE); 2/5/24It could come today. Or in a few weeks. Maybe within the next month.Whenever it happens, rescheduling marijuana under the Controlled Substances Act – which regulates what drugs are considered illegal and just how illegal they are – would be the biggest step the federal government has taken toward marijuana legalization since it was first outlawed nearly 100 years ago.

Cannabis for neurodegenerative disordersCannabis - Science and Technology, by Ruth Fisher; 1/30/24In this blog installment, we take a deep dive into research on how cannabis affects neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease. ... The information presented in this section comes from the Cleveland Clinics, a nonprofit academic medical center.